News | Structural Heart | July 05, 2019

FEops HEARTguide Wins CSI Highlight of the Year Award

Software helps physicians evaluate device sizing and positioning pre-operatively for TAVI and left atrial appendage occlusion procedures

FEops HEARTguide Wins CSI Highlight of the Year Award

July 5, 2019 — FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by physician attendees for the Highlight of the year award in the interventional imaging category. This award celebrates promising technologies that will have the biggest impact in the field, on daily practice or on patients’ health and outlook. Cameron Dowling, M.D., St George’s, U.K., and Martin Swaans, M.D., Ph.D., St. Antonius, The Netherlands, shared their early experience with patient-specific computer simulation of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve morphology.

FEops HEARTguide, which received CE mark earlier this year, is a procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology. The current release includes workflows for TAVI and left atrial appendage occlusion (LAAO) procedures.

In addition to the Highlight of the year award, FEops HEARTguide was also starring in two best poster awards at CSI: 

  • Best poster in TAVI, commented by Dowling and focusing on the impact of FEops HEARTguide on heart team decision making for TAVI in patients with bicuspid aortic valves; and 
  • Best poster in LAA Occlusion, where A. Bavo, FEops, Belgium, presented the validation data for the LAAO workflow within FEops HEARTguide. 

Dowling stated, “This award recognizes the outstanding work undertaken by the FEops team in developing patient-specific computer simulations for structural heart interventions.”

FEops HEARTguide cloud-based procedure planning environment uses advanced personalized computational modeling and simulation to provide clinicians and medical device manufacturers with insights into the interaction between transcatheter structural heart devices and specific patient anatomy – preoperatively. The current release includes TAVI and LAAO workflows. Such insights have the power to accelerate research and development of novel device-based solutions, as well as ultimately help to improve clinical outcomes in real-world hospital settings.

Read the article "FEops Closes Financing to Commercialize TAVIguide Service"

For more information: www.feops.com

Related Content

TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
htisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...